بسم الله الرحمن الرحيم.

Slides:



Advertisements
Similar presentations
MUSCULAR SYSTEM.
Advertisements

Duchenne Muscular Dystrophy: Rehabilitation Management
Muscular Dystrophy Kate DeAngelis AP Biology 1/6/09 Kate DeAngelis AP Biology 1/6/09 Charles DeAngelis:
Duchenne Muscular Dystrophy: Orthopaedic Management.
Bell’s Palsy, Muscular Dystrophies -Erb’s Palsy Victor Politi, M.D., FACP Medical Director, SVCMC, School of Allied Health Professions, Physician Assistant.
MİYOPATİLER Prof.Dr.Aytekin Akyüz CÜ Tıp Fak Nöroloji AD.
Activity and Exercise. Key Terms 1. Abduction – Movement away from body. 2.Active Range of Motion – Range of motion exercises completed by the resident.
The molecular basis of muscular dystrophy ( 肌营养不良 ) Wenya Hou Xue Jing Yitang Wang Jiezhong Zhang.
Muscular Dystrophy By: Krystal Freeman. Is What? Is a genetic disorder that weakens the muscles that help the body move. is a group of disorders that.
 Muscular Dystrophy (MD) is a group of inherited muscle diseases, in which muscle fibers are unusually susceptible to damage. Muscles, primarily voluntary.
Approach to myopathy Dr omid yaghini MUSCLES DISORDERS Definition: Diseases involving the muscle fibers (myogenic) Unlike: neuronopathies: secondary.
Muscular Dystrophy Definition Refers to a group of hereditary progressive diseases. Muscular Dystrophy affects muscular strength and action, some of which.
Muscle Disease Neurology Rotation Lecture Series Last Updated by Lindsay Pagano Summer 2013.
Duchenne Muscular Dystrophy
D UCHENNE ’ S M USCULAR D YSTROPHY Kate Chipchase Vts teaching Feb 2012 ST2.
Muscular Dystrophy Dayna Ryan, PT, DPT Winter 2012.
By: Alisha Kunz, Julia Rodenberg, Tyler Traisman and Nathan Wegner Goanimate.
Muscular Dystrophies Patarawan Woratanarat, MD, PhD Department of Orthopaedics Faculty of Medicine Ramathibodi Hospital.
Myopathy and muscular dystrophy Dr. abeer kawther.
MYOPATHY Dr.Shamekh M. El-Shamy. Definition: Myopathies are a group of diseases of the skeletal muscles characterised by gradual progressive degeneration.
Greyson P. Cole W. Corinne H.
Muscular dystrophy. By: Eric Rubio.
Muscular Dystrophy. What it is… Muscular Dystrophy is a family of hereditary disease that cause progressive and steady muscle weakening. Duchenne and.
Duchenne Muscular Dystrophy
Human Genetic disorders
Commonly referred to as DMD The disease was first described by the Neapolitan physician Giovanni Semmola in 1834 and Gaetano Conte in 1836 DMD is named.
Diseases of musculoskeletal system
Sally Freese Family and Consumer Science
Muscular System.
Muscular Dystrophy By Jessica Wang.
Duchenne Muscular Dystrophy
Myotonic Disorders. Myotonia Definition: A prolonged failure of relaxation with after- discharge on the EMG Features: Requires strong contraction for.
(DMD) Duchenne Muscular Dystrophy. History of DMD It was first described by a french neurologist named Guillaume Benjamin Amand Duchenne in Previous.
Ashley Webb. Definition Muscular dystrophy (MD) is a group of rare inherited muscle diseases in which muscle fibers are unusually susceptible to damage.
Contractures.
MUSCULAR DYSTROPHY BY ALBERT DIPPEL, ISAAC MOODIE, NYLEAH MORRIS-BROWN.
Mechanical principals of equipment in the gymnasium.
Primary muscle disease Commonest is Duchene muscular dystrophy (DMD) Presence in early childhood Genetic disease Absence or mutation of gene responsible.
Chapter Body Mechanics Activity and Exercise.  Refers to persons routines of exercise, activity, leisure and recreation needs for rest and mobility.
DISEASES OF MUSCLE.
Muscular System 7.5 Over 600 muscles make up the muscular system Muscles are made of bundles of muscle fibers that are held together by connective tissue.
Charcot-Marie- Tooth Disease Jessica Tzeng. History  Named after Jean-Martin Charcot, Pierre Marie (Charcot’s pupil), and Howard Henry Tooth  Not a.
Motor neuron disease.
By: Alisha Kunz, Julia Rodenberg, Tyler Traisman and Nathan Wegner Goanimate.
Muscular Dystrophies group of inherited myopathic disorders characterized by progressive muscle weakness and wasting. A number of skeletal muscle genes.
Skeletal muscle diseases a. The muscular dystrophies. - Describe their pathogenesis. - Describe their morphology. - Discuss their clinical picture and.
Copyright © 2013 by Mosby, an imprint of Elsevier, Inc. MOBILITY.
Skeletal muscle diseases
Fibromyalgia Chronic, widespread pain in specific muscle sites. Symptoms: Muscle stiffness Numbness or tingling in the arms or legs Fatigue Sleep disturbances.
Hypotonia, neuropathies and myopathies
Hydrotherapy In Child With Progressive Muscular Dystrophy (Case Study)
Multiple Sclerosis. Multiple sclerosis (MS) is a disease that affects central nervous system (brain and spinal cord). It damages the myelin sheath. 
Muscular System  The body has more than 600 muscles that make up 40 to 45% of the body’s weight.
movement impairment syndrome of the humerus
2) Knee.
Humeral Anterior Glide Syndrome
Muscular system 7.4. Muscular System 600+ muscles in the body Muscles are bundles of muscle fibers held together by connective tissue Properties of muscles:
-SHUCHI JOSHI ARIP :30-2:30.   Muscular Dystrophy (MD) is a group of inherited diseases in which the voluntary muscles progressively weaken.
Body Mechanics Activity and Exercise CONCEPT OF NURSING
Range of Motion Exercise(ROM)
Conditions in Occupational Therapy 5th edition Ben J
Chapter 13 Muscles, Bones, and Nerves
Muscular Dystrophy.
Muscle Dystrophy Jon Durrani, DO Attending Neurologist
By: Kelli Novak & Katelyn Thompson
MUSCULAR SYSTEM.
MUSCULAR SYSTEM.
Duchenne’s muscular dystrophy
Presentation transcript:

بسم الله الرحمن الرحيم

Approach to myopathy Hereditary & Acquired Hereditary Myopathy Classification Dystrophy Congenital myopathy Channelopathies & myotonia Metabolic (fatty acid/glycogensis/mitochondrial)

Muscular dystrophy Inherited myopathy characterized by progressive muscles weakness &degeneration &subsequent replacement by fibrous & fatty connective tissue .

Muscular Dystrophy affects muscular strength and action, some of which first become obvious in infancy, and others which develop in adolescence or young adulthood. The syndromes are marked by either generalized or localized muscle weakness, difficulties with walking or maintaining posture, muscle spasms, and in some instances, neurological, behavioral, cardiac, or other functional limitations

Classification of Muscular Dystrophy Sex-linked: DMD, BMD, EDMD Autosomal recessive: LGMD, infantile FSHD Autosomal dominant: FSHD, distalMD, ocular MD, oculopharyngeal MD.

Progressive Muscular Dystrophy Type Onset Age (years) Clinical Features Other organ systems involved Duchenne Before 5 Progressive weakness of girdle muscles. unable to walk after age 12 progressive kyphoscoliosis Respiratory failure in 2dor 3d decade. Cardiomyopathy Mental impairment Becker 5-25yr early childhood to adult Progressive weakness of girdle muscles 2. able to walk after age 15. 3. respiratory failure may develop by 4th grade Emery-Dreifuss Childhood to adult Elbow contractures, humeral and perineal weakness Limb-Girdle Slow progressive weakness of shoulder and hip girdle muscles

Progressive Muscular Dystrophy Type Onset Age (years) Clinical Features Other organ systems involved Congenital At birth or within 1st few months .Hypotonia, contractures, delayed milestones Progression to respiratory failure in some; CNS and Eye abnormalities Facioscapulohumeral Before age 20 Slowly progressive weakness of face, shoulder girdle, and foot dorsiflexion Deafness Coat’s (eye) disease Oculopharyngeal 5th to 6th decade Slowly progressive weakness of extraocular, pharyngeal, and limb muscles ______ Myotonic Usually 2nd decade May be infancy if mother affected Cardiac conduction defects Mental impairment Cataracts Frontal baldness Gonadal atrophy

Duchenne MD Incidence: 1/3500 male birth 1/3 new mutation c/p:as early as 2-3y with delay milestones Progressive limb girdle pattern Fall 5-6y/difficult climb stair 8y, confined to wheelchair 12y

DMD: Clinical manifestation Onset : age 3-6 years Progressive weakness Pseudohypertrophy of calf muscles Spinal deformity Cardiopulmonary involvement Mild - moderate MR

DMD: Diagnosis Gower’s sign

DMD: Natural history Progress slowly and continuously muscle weakness ( lower --> upper extremities, Progressive kyphscliosis due to Paraspinal muscles weakness unable to ambulate: 10 year (7-12) death from pulmonary/ cardiac failure: 2-3rd decade

Beckers MD Is milder form 5/100,000 Age :5-15y Wheelchair at 30y Equinous and varus foot High rate of scoliosis Cardiac similar to duchenne Death by age 40

Emery-dreifuss X linked onset :childhood Triad of: 1-early contracture elbow, ankle &posterior cervical 2-progressive scapulohumroperoneal 3-cardiomyopathy with atrial conduction defect

EDMD Natural history Diagnosis 1st 10 y: mild weakness Gower’s sign Later: contracture, cardiac abnormality 5th-6th decade: can ambulate Poor prognosis in obesity, untreated equinus contractures. Diagnosis Gower’s sign Mildly/moderately elevated CPK EMG: myopathic Normal dystrophin

Limb girdle dystrophy Classification Clinical manifestation AR majority Onset: adolescence or late Clinical manifestation Slow progression, contracture & disability Rarely significant scoliosis Classification Pelvic girdle type common Scapulohumeral type rare

Fascioscapulohumeral muscular dystrophy Autosomal dominant Epidemiology Female > male Clinical manifestation Age of onset: late childhood/ early adult - No cardiac, CNS involvement Muscle weakness ( face, shoulder, upper arm ) Lack of facial mobility Incomplete eye closure Pouting lips Transverse smile Absence of eye and forehead wrinkles Sparing Deltoid Distal pectoralis major Erector spinae

FSMD: Clinical manifestation Winging scapula Markedly decreased shoulder flexion & abduction Horizontal clavicles forward sloping Rare scoliosis

Congenital muscular dystrophy Autosomal recessive c/p: Hypotonia &proximal weakness, arthrogryposis, Stiffness of joint, Congenital hip dislocation, subluxation Achillis tendon contracture, talipes equinovarus,Scoliosis Two types CNS involvement: sever mental retardation ,visual, seizure ..cerebrocular dysplasia, progressive death by age 10-12 No CNS :classic type MRI (hypomyelination), benign outcome, non progressive Muscle biopsy :dystrophy…

Myotonic dystrophy Autosomal dominant Affect : skeletal,cardiac, smooth muscles, eye,endocrine &brain Onset :at any age ,usually at late 2nd decade Some individual can be symptoms free their entire life Sever form :congenital myotonic dystrophy C/P: weakness: (facial,temporalis wasting,ptosis,neck flexor,distal weakness progress to involve limb girdle)

oculopharengeal Autosomal dominant Onset:5th &6th decade Ptosis &dysphagea later all extra ocular muscles &extremities affected (limb girdle) but distal can be significant in some variant Slow progressive ,death from aspiration pneumonia or starvation

Congenital myopathy Are distinguished from dystrophy in three respect: Characteristic morphologic alteration At birth Non progressive c/p: hypotonia with subsequent developmental delay Reduce muscles bulk, slender body build &long narrow face Skeletal abnormalities: high arched palate ,pectus exacavitum, kyphscliosis, dislocated hip, pes cavus) Absent or reduced muscle stretch reflex Weakness: limb girdle mostly, but distal weakness exist

Muscular Dystrophy: Rehabilitation Management

Respiratory Management Patients with DMD are at increased risk of respiratory complications Because of progressive loss of muscle strength: Cough may be ineffective Nocturnal hypoventilation Sleep-disordered breathing PT can assist with respiratory management by having patient breathe against a resistive load (water in pool), breath-holding, bubble-blowing, to improve ventilatory strength and endurance. Important to note signs and symptoms of hypoventilation to refer patient to respiratory physician. Fatigue, dyspnea, tachycardia, morning/continuous headaches, sleep dysfunction, nightmares, difficulty concentrating

Cardiac Management Cardiomyopathy and/or cardiac arrhythmia are major sources of mortality in DMD The heart/myocardium have areas of hypertrophy, atrophy, and fibrosis Failure to see a cardiac specialist early in the disease process have led to late treatment and poor outcomes Higher levels of fitness are associated with better cardiac health

Goals of Physical Therapy Prolong independent ambulation Maximize functional ability Prevent complications of inactivity Improve emotional well-being Physical Therapy Interventions Stretching/Positioning Management of contractures Assistive devices Exercise Objective measures and testing to monitor progression

Objective measures Strength testing- MMT to monitor disease progression and predict functional losses, assess responses to treatment and monitor muscle imbalances Test Lower exermiies every 6 months when ambulatory; test UE and LE every 6 months when non-ambulatory ROM: goniometry to identify hypomobility, jt contractures that may contribute to functional deterioration or to musculoskeletal/integumentary complications, or to note need of splinting/orthotics. In ambulatory phase, measure hips, knees, ankles (ITB, H/S, heelcords). In non-ambulatory phase, measure UE as well as LE (elbows, wrists, finger flexors)

Stretching Combination of AROM, AAROM, PROM, prolonged elongation (splinting, positioning) Minimum of 4-6 days per week, at home/school and in the clinic Heelcords: Gastrocnemius/ Achilles Tendon lengthening into dorsiflexion Tensor Fascia Latae/Iliotibial Band: stretch hip into adduction, internal rotation, and extension. Other muscles throughout the hips, knees and ankles In non-ambulatory phase, also focus on upper extremities: finger flexors, wrist flexors, elbow and shoulder joints Positioning at night/ daily TFL stretch_ to oppose positional seating in W/C

Active assisted stretches Self stretches Ilio-tibial band (ITB)

Assistive Devices: AFOs Custom-molded and comfortable for optimum foot and ankle alignment Throughout life: AFO’s are appropriate at night to prevent or minimize the progression of equinus contractures Late stages: KAFOs for non-ambulatory boys to prevent contracture and deformity (not for use at night) Resting hand splints for finger flexors

Assistive Devices Con’t Wheelchair: Need appropriate postural positioning to prevent scoliosis and back pain/aches Powered for more involved patients. Manual Lightweight for less involved patients so can self propel and increase independence, as well as provide arm exercise Standing Frames: A few hours per day, even with minimal weight bearing, to prevent and reduce the severity of contractures, decubitis ulcers, and scoliosis. Also improves bone mineral density, circulation, and GI and respiratory functions. Tilting wheelchairs into a standing position also Wheelchairs: important to include reclining backrest, raisable leg rests, appropriate padding

Recommended Exercise for DMD Low resistive and aerobic exercise are justified to: Prevent deconditioning, decreased fitness, disuse atrophy and joint contractures Counteract secondary complications of inactivity such as obesity, Diabetes, osteoporosis and cardiovascular diseases Long term, low-intensity, preferably no load (or low-load) weight-bearing activity to reduce mechanical stress on the muscle Increased Type I fibers, which are less vulnerable to degeneration Will not promote hypertrophy

Recommended Exercise for DMD, Con’t Use caution to ensure that cardiovascular or muscular complications do not develop High-resistance and eccentric exercise is NOT recommended, although it has not actually been proven harmful for a DMD patient Aquatic Therapy! Excellent for improving/ maintaining mobility, strength, flexibility, and aerobic conditioning and cardiopulmonary fitness Limited research on frequency, intensity, and type of ex

thanks